In both the proximal colon and distal colorectal cancer networks, we observed common biomarkers that positively correlated with MSI including methylation-related markers, BRAF mutation, and immune reactions, while overexpression or loss of protein expression associated with MSI were further found only in the proximal colon cancer network. This evidence concerns the gene BRAF and colonic neoplasm.